Enjoy complimentary customisation on priority with our Enterprise License!
The endoscopic vessel harvesting market size is forecast to increase by USD 118 million at a CAGR of 4.5% between 2023 and 2028. The Endoscopic Vessel Harvesting (EVH) market is experiencing significant growth due to the increasing volume of endoscopic procedures and a growing target population. This trend is particularly noticeable in emerging countries where the number of minimally invasive increaseries is on the rise. However, the market also faces challenges, including stringent regulations and product recalls. To mitigate infection risk, there is a growing emphasis on hygiene and the use of reusable EVH systems. Near-infrared fluorescence imaging is another emerging trend, enabling better visualization of the saphenous vein and internal mammary artery during the harvesting process. Overall, the market presents high growth potential, but companies must navigate regulatory hurdles and maintain a focus on patient safety and quality to succeed.
The Endoscopic Vessel Harvesting (EVH) market in the US is witnessing significant growth due to the increasing prevalence of cardiovascular diseases, such as coronary artery disease, peripheral artery disease, and ischemic heart disease. These chronic conditions often require surgical interventions, including vessel harvesting for bypass grafts. EVH systems, which utilize endoscopes and accessories, offer improved usability and reduced trauma compared to traditional open tunnel harvesting methods. The market caters to various vessel types, including saphenous vein, radial artery, and others. Both disposable and reusable EVH systems are available, offering flexibility based on clinical requirements and cost considerations.
Furthermore, the American Heart Association advocates for minimally invasive techniques to improve patient outcomes and reduce healthcare costs. Near-infrared fluorescence imaging is a valuable addition to EVH systems, ensuring precise vessel identification and minimizing the risk of complications. In summary, the US the market is poised for growth, driven by the increasing burden of cardiovascular diseases and the demand for minimally invasive techniques. The market caters to various vessel types and offers both disposable and reusable systems to cater to diverse clinical needs.
The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The disposable EVH system segment is estimated to witness significant growth during the forecast period. Endoscopic Vessel Harvesting (EVH) is a minimally invasive procedure used to obtain a healthy blood vessel for coronary artery bypass grafting (CABG). EVH employs disposable, single-use endoscopic systems to access the blood vessel through a small incision, typically less than an inch long. This approach offers numerous benefits over traditional open procedures, including reduced risk of infection and wound complications, less postoperative discomfort and swelling, and faster recovery time with minimal scarring.
Furthermore, EVH allows for greater precision and flexibility during the procedure, making it an attractive alternative to catheter-based therapies such as angioplasty. The use of reusable components in EVH systems minimizes overall costs and reduces waste, making it a cost-effective solution for patients undergoing CABG. In numerous clinical trials, EVH has demonstrated superior patient satisfaction compared to open procedures. Minimally invasive harvesting techniques, such as endoscopic vein harvesting (EVH), are increasingly being adopted by both multinationals and small to mid-sized companies to enhance surgical outcomes and improve patient recovery in various vessel types.
Get a glance at the market share of various segments Request Free Sample
The disposable EVH system segment accounted for USD 267.40 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 49% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
For more insights on the market share of various regions Request Free Sample
The market in the US is experiencing significant growth due to the rising prevalence of chronic conditions such as arthritis, Gastrointestinal (GI) diseases, and ENT disorders. These diseases necessitate diagnostic medical procedures like endoscopy to examine the interior of the body and organs, which cannot be achieved through conventional methods. Moreover, the increasing awareness among patients regarding various diseases and the significance of preventive healthcare is fueling market growth. For instance, key market players like Olympus promote Colon Cancer Awareness Month annually to raise awareness and organize related programs.
Furthermore, catheter-based therapies and angioplasty are other areas where endoscopic vessel harvesting is gaining traction due to their minimally invasive nature. The market is further boosted by the availability of both single-use endoscopic vessels and reusable components, catering to various customer preferences and budgets.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
Increasing volume of endoscopic procedures coupled with growing target population is the key driver of the market. The use of minimally invasive Endoscopic Vessel Harvesting (EVH) techniques has witnessed notable growth in the American healthcare sector. Chronic diseases, such as ischemic heart disease, have become increasingly prevalent due to lifestyle changes and an aging population. According to the Centers for Disease Control and Prevention (CDC), approximately 60% of American adults have at least one chronic condition, with 40% of these individuals managing two or more. These conditions account for approximately 86% of the country's USD 2.7 trillion annual healthcare expenditure. In 2021, 3,817 heart transplants were performed in the US, highlighting the significant need for advanced cardiovascular treatments.
Furthermore, the American Heart Association advocates for the adoption of minimally invasive procedures like EVH to improve patient outcomes and reduce trauma and pain associated with traditional surgical methods.
High growth potential in emerging countries is the upcoming trend in the market. The market is witnessing significant growth due to the increasing prevalence of chronic diseases such as ischemic heart disease and trauma in the American population. Minimally invasive techniques have gained popularity in the healthcare sector, and Endoscopic Vessel Harvesting is one such technique that offers several advantages over traditional open heart. The American Heart Association recommends the use of minimally invasive procedures to reduce pain and complications for patients. Emerging economies are becoming key contributors to The market due to their vast growth opportunities. Government initiatives, improved healthcare infrastructure, and better economic conditions are attracting market companies to expand their presence in these regions.
For instance, the Japanese government is promoting the usage of advanced medical devices and procedures in emerging economies by organizing conferences and awareness programs in collaboration with companies. This is expected to increase the adoption rate of Endoscopic Vessel Harvesting and generate substantial revenues for market players.
Stringent regulations and product recalls is a key challenge affecting the market growth. Endoscopic Vessel Harvesting (EVH) is a minimally invasive technique used in the extraction of blood vessels for bypass grafting during cardiac surgeries. The American Heart Association prioritizes the importance of addressing chronic diseases, such as ischemic heart disease, through advanced medical procedures. EVH is classified as a Class II medical device, subject to rigorous regulatory approval processes.
Moreover, these standards ensure safety and efficacy but can pose challenges for manufacturers. Clinical trials are a significant hurdle, as positive results in one region can influence the success of trials in others. Strict labeling requirements and regulatory frameworks further complicate product launches. Despite these challenges, the demand for minimally invasive techniques in cardiac procedures continues to grow, driven by the need to reduce trauma and pain for patients.
The market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.
Cardio Medical GmbH - The company offers soft tissue retractor sterling device which is designed to implement retraction during surgical operation.
The market research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Endoscopic Vessel Harvesting (EVH) systems have revolutionized the field of cardiovascular interventions by providing minimally invasive solutions for harvesting saphenous veins and internal mammary arteries. These systems utilize endoscopes and accessories for accessing and extracting vessels with enhanced usability and flexibility. EVH systems cater to various cardiovascular conditions, including coronary artery disease, peripheral artery disease, and ischemic heart disease, offering alternatives to traditional open tunnel harvesting techniques. The geriatric population and the shift towards episode-based payment models have fueled the demand for EVH systems due to their minimal trauma, reduced pain, and faster recovery time. Reusable EVH systems and disposable single-use endoscopic vessels ensure cost-effectiveness and infection control, addressing the concerns of hygiene and infection risk.
Moreover, hospitals and ambulatory surgical centers have increasingly adopted EVH systems for their minimally invasive techniques, aligning with the American Heart Association's focus on chronic diseases and catheter-based therapies. The market landscape depends on the Hospital Readmissions Reduction Program, Peripheral arterial disease (PAD), Coronary artery disease (CAD), Single-use endoscopic vessel, Saphenous vein vessel, Closed tunnel harvesting technique, Minimally invasive surgical techniques, Peripheral vascular disease (PVD), Coronary artery bypass graft, Disposable EVH systems. The market for EVH systems continues to grow, driven by the increasing prevalence of cardiovascular diseases and the need for efficient, safe, and effective vessel harvesting solutions.
Market Scope |
|
Report Coverage |
Details |
Page number |
134 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 4.5% |
Market growth 2024-2028 |
USD 118 million |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
4.23 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 49% |
Key countries |
US, Germany, UK, China, and Japan |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
Cardio Medical GmbH, CardioPrecision Ltd., Conmed Corp., ELITE LIFECARE, Getinge AB, HOYA CORP., Johnson and Johnson Services Inc., KARL STORZ SE and Co. KG, LivaNova PLC, Med Europe Srl, Medical Instruments SpA, Medtronic Plc, Olympus Corp., Saphena Medical Inc., Smith and Nephew plc, Stryker Corp., Teleflex Inc., Terumo Corp., Troge Medical GmbH, Xcellance Medical Technologies Pvt. Ltd., and Zimmer Biomet Holdings Inc. |
Market dynamics |
Parent market analysis, market growth inducers and obstacles, market forecast, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, market condition analysis for the forecast period |
Customization purview |
If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Get the report (PDF) sent to your email within minutes.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.